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ABSTRACT A wide diversity of fungi have been detected in the human gastrointes-
tinal (GI) tract with the potential to provide or influence important functions. How-
ever, many of the fungi most commonly detected in stool samples are also present
in food or the oral cavity. Therefore, to recognize which gut fungi are likely to have
a sustained influence on human health, there is a need to separate transient mem-
bers of the GI tract from true colonizers. To identify colonizing fungi, the eukaryotic
rRNA operon’s second internal transcribed spacer (ITS2) was sequenced from the
stool, saliva, and food of healthy adults following consumption of different con-
trolled diets. Unlike most bacterial 16S rRNA genes, the only fungal ITS2 operational
taxonomic units (OTUs) detected in stool DNA across multiple diets were also pres-
ent in saliva and/or food. Additional analyses, including culture-based approaches
and sequencing of the 18S rRNA gene, ITS2 cDNA, and DNA extracted using alterna-
tive methods, failed to detect additional fungi. Two abundant fungi, Saccharomyces
cerevisiae and Candida albicans, were examined further in healthy volunteers. Sac-
charomyces became undetectable in stool when a S. cerevisiae-free diet was con-
sumed, and the levels of C. albicans in stool were dramatically reduced by more fre-
quent cleaning of teeth. Extremely low fungal abundance, the inability of fungi to
grow under conditions mimicking the distal gut, and evidence from analysis of other
public datasets further support the hypothesis that fungi do not routinely colonize
the GI tracts of healthy adults.
IMPORTANCE We sought to identify the fungi that colonize healthy GI tracts and
that have a sustained influence on the diverse functions of the gut microbiome. In-
stead, we found that all fungi in the stool of healthy volunteers could be explained
by their presence in oral and dietary sources and that our results, together with
those from other analyses, support the model that there is little or no gastrointesti-
nal colonization by fungi. This may be due to Westernization, primate evolution, fun-
gal ecology, and/or the strong defenses of a healthy immune system. Importantly,
fungal colonization of the GI tract may often be indicative of disease. As fungi can
cause serious infections in immunocompromised individuals and are found at in-
creased abundance in multiple disorders of the GI tract, understanding normal fun-
gal colonization is essential for proper treatment and prevention of fungal patho-
genesis.
KEYWORDS colonization, diet, fungi, gastrointestinal tract, mycobiome, saliva
There are fungi in the gastrointestinal (GI) tracts of all healthy people (1), where theycan impact the immune system (2) and produce secondary metabolites that
influence health (3, 4). One fungal strain, Saccharomyces cerevisiae var. boulardii, is also
commonly used as a probiotic to treat gastrointestinal disorders (5). However, fungi in
the GI tract have been associated with numerous diseases based on case-control
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studies (see, e.g., reference 6) and may also contribute to the millions of invasive fungal
infections that occur in immunocompromised individuals every year (7). Considering
that ~0.01% to 0.1% of metagenomic reads from adult stool samples have mapped to
fungal species (8, 9) and that fungal genomes are ~3 to 10 times larger than bacterial
genomes, it is possible to estimate that of the 1013 microorganisms in the GI tract
(10), about a billion compose what is often referred to as the gut mycobiota or
mycobiome (11).
A recurring issue in studies of fungi in the GI tract is how many of the detected fungi
are true colonizers in contrast to those transiently passing through the GI tract from
other sources such as food, the environment, or the nasal or oral cavities (12). Unlike
bacteria, archaea, and some protists, the fungi detected in stool by ribosomal internal
transcribed spacer (ITS) amplification and sequencing typically have little longitudinal
stability across samples from a single person (1). Most commonly detected fungal
genera have representatives present in food and/or the oral cavity (13–15), and some
are known to increase in abundance in stool following consumption of certain foods
(16). Therefore, any fungal commensals possibly colonizing the GI tract may be ob-
scured in experiments that do not control for the presence of transient fungi.
We sought to differentiate transiently present fungal species from those that
colonize the GI tract. However, our controlled-diet and dental hygiene experiments
suggested that all of the fungi detected were transiently associated and therefore that
possibly no fungi had colonized the GI tracts of the individuals examined. Analyses of
large public gut microbiome data sets and the failure of fungi to grow under gut-
simulating conditions lend growing evidence to support the hypothesis that fungi are
excluded from colonizing the GI tracts of most healthy Western adults.
RESULTS
Examining patterns in fungi detected in the stool of Human Microbiome
Project volunteers. Because the environment of the GI tract limits colonization to
certain organisms, with sufficient sampling, a large portion of the total diversity of
colonizers can be identified and the detection of new organisms plateaus. In contrast,
transient populations would not be required to survive in the gut and therefore would
not have the same restrictions on diversity. The fungi present in stool samples of
healthy adults in the Human Microbiome Project (HMP) cohort were previously exam-
ined through amplification and sequencing of the eukaryotic rRNA operon’s second
internal transcribed spacer (ITS2) (1). We examined the rate at which new fungal ITS2
operational taxonomic units (OTUs) could be detected in HMP stool samples and
compared this to the rate of detection of new 16S rRNA gene OTUs using all samples
that had at least 1,000 reads from each analysis (148 shared samples from 100
volunteers). Sequences from both regions were clustered into OTUs at 97% identity,
which is roughly species level (17). For individual samples, the number of unique ITS2
OTUs was typically lower than that of 16S rRNA gene OTUs. However, when at least 70
samples were examined, ITS2 diversity surpassed that of 16S rRNA genes (Fig. 1). When
all 148 samples were included, there were 501 ITS2 OTUs, compared to 385 16S rRNA
gene OTUs. The addition of new OTUs most closely follows a power function for ITS2
and a logarithmic curve for 16S rRNA genes. This difference in the rates of identifying
new OTUs is consistent with the possibility that most of the detected fungi were
ultimately derived from the consumption of different foods, which contain, as a whole,
more unique microorganisms than those that may be colonizing the GI tract.
We further analyzed the data to identify the specific fungal taxa consistently present
over time. There were 42 volunteers with three longitudinal samples containing at least
1,180 (mean, 54,880) nonplant ITS2 reads each. Although there was a mean of 10.3
(range, 2 to 32) ITS2 OTUs present at 10 reads/sample, only OTUs representing
Saccharomyces cerevisiae (30 volunteers) and Malassezia restricta (19 volunteers) were
present at all sampling points for two or more volunteers (see Table S1 at https://
github.com/auchtung/Auchtung2018). However, it is possible that additional, low-
abundance fungi were present but obscured by the various fungal species found
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associated with foods and that they could be discovered by examining the stool of
volunteers that consumed controlled diets of known fungal composition.
Examining fungi in the stool of volunteers across different controlled diets. To
identify fungi colonizing the human GI tract, each of four healthy Western adult
volunteers (volunteer 1 [V1] to V4) of diverse geographical and dietary backgrounds
consumed the same sequence of four predefined diets of nuts and dried berries
(A); beans, rice, and corn (B); pasta and marinara sauce (C); and an egg, sausage, and
cheese sandwich and peas (D) (see Table S2A and B at https://github.com/
auchtung/Auchtung2018). The diets were selected for their representation of major
food groups, their relatively low fungal load, and their simplicity, which allowed all
components to be sequenced to identify the fungi present. Saliva samples were
collected throughout, and the second stool sample seen to contain food or dye from
the particular diet was collected (the time of collection differed among the samples but
was typically 2 days after the volunteer commenced the diet). All volunteers also
provided stool and saliva samples on a day when they consumed their regular
(uncontrolled) diet. Concurrently, a fifth healthy volunteer (V5) on an uncontrolled diet
also donated stool samples. Fungi present in stool, saliva, and controlled-diet compo-
nents were examined by sequencing the ITS2 region from extracted DNA. Orthogonal
approaches were taken to ensure that no fungi in stool went undetected, including
amplifying and sequencing ITS2 cDNA from reverse-transcribed RNA and 18S rRNA
genes from DNA, examining fungi in DNA extracted by different methods, and culturing
viable fungi. For comparison, the bacterial and archaeal community was examined by
16S rRNA gene sequencing as necessary.
The abundance of ITS2 and 16S rRNA genes in DNA extracted from stool was
examined by quantitative PCR. ITS2 copies were 680 to 7,600 (mean, 3,000) times
less abundant than 16S rRNA genes (see Fig. S1 at https://github.com/auchtung/
Auchtung2018). The ITS2 region was also amplified from stool DNA for sequencing on
an Illumina MiSeq platform (2  300 bp). A high fraction of sequence reads from all
controlled-diet volunteers matched plant sequences (see Table S2C and Fig. S2 at
https://github.com/auchtung/Auchtung2018; V1  68%, V2  42%, V3  94%, and
V4  91%). These matched either foods consumed in the controlled diets (see Ta-
ble S2D at https://github.com/auchtung/Auchtung2018; Prunus almonds in diet A and
Pisum peas in diet D) or foods previously consumed by the volunteers, particularly
those associated with seeds (Rubus raspberries in V1, Linum flax in V2, Amaranthus of
unknown origin in V3, and Psidium guava and Solanum tomatoes in V4). Volunteers 3
FIG 1 Comparison of community fungal and bacterial/archaeal diversity levels. Numbers of unique ITS2
(blue circles) or 16S rRNA gene (orange diamonds) OTUs in 148 Human Microbiome Project samples
(from 100 volunteers) that had been rarefied to 1,000 reads for both regions were determined. Plotted
data represent the mean number of OTUs detected at the indicated number of samples when sample
order was randomized over 1,000 iterations. The error bars represent the 95% confidence intervals. The
ITS2 data most closely fit the power function y 17.34x0.68 (R2 0.998), whereas the 16S rRNA gene data
most closely fit the logarithmic equation y  79.03ln(x) 17.84 (R2  0.988).
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and 4 had no memory of having consumed amaranth or guava within 2 weeks of the
study, suggesting that they represented a minor component of the fecal material and
were detected only because of the small amount of fungi present and the slow transit
times of seeds. The relative amount of plant reads was greater than that observed in V5
and HMP volunteers (both 16%), possibly due to the controlled diets being relatively
low in fungi and high in plants that amplify well with the primers employed.
When plant reads were removed from the ITS2 DNA data, the volunteers had high
levels of fungi that corresponded to species abundant in their saliva, to species
abundant in foods that the volunteers reported frequently consuming during their
regular diet, or to species abundant in foods that were components of the experimental
diet: Candida albicans (saliva) or Penicillium sp. (blue cheese) in V1, C. albicans (saliva)
and/or Saccharomyces (multiple foods) in V2, Phoma herbarum (saliva and beer) in V3,
and Aspergillus niger (nut mix) (18) in V4 (Fig. 2; see also Table S2D and E at https://
github.com/auchtung/Auchtung2018). In addition, all volunteers had detectable levels
of A. niger in diet A (multiple nuts and fruits) and Saccharomyces in diets B (corn) and
D (bread).
Considering the unrarefied ITS2 DNA sequences from stool of the four controlled
diets, there were 60 fungal OTUs in total but just 10 OTUs that were found in two or
FIG 2 Relative abundances of fungal taxa detected by ITS2 DNA and cDNA analysis of stool samples from volunteers 1 to 4 following controlled diets A to
D and the presence of those taxa in the saliva of the volunteers, components of the controlled diets, and known components of the volunteers’ regular diets.
Stool DNA, stool cDNA, saliva, and controlled-diet samples had median read values of 24,655, 10,527, 18,540, and 18,500, respectively. For stool, the relative
abundances for triplicate samples were averaged and sequences mapping to plants were removed. Samples with1,000 reads remaining were rarefied to 1,000
reads. For saliva, there were 10 to 12 samples analyzed per volunteer that were collected across the diets. For controlled-diet components, two samples were
analyzed (typically one whole sample and one sample rinse). A species was considered present if detected at10 reads in any replicate of a sample. The species
detected from stool samples of 1 diet of a volunteer are indicated with coloring. Regular diet components were those foods volunteers reported typically
eating.
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more stool samples from any volunteer (see Table S2C at https://github.com/auchtung/
Auchtung2018; an OTU was considered present if there were at least 10 reads in any
replicate of a sample). Of those 10 OTUs, 8 were also detected in saliva, and 8 were also
detected in food. The 10 OTUs included those at the highest relative abundance
(mentioned above): C. albicans, Penicillium sp., Saccharomyces, P. herbarum, and A. niger,
plus Geotrichum candidum (other than in controlled-diet C, where it was detected in the
pasta, it was detected only in V2 diet D stool samples, possibly due to the presence of
cheese in the regular diet consumed by V2), Cladosporium sp. (a common mold in the
environment, detected at low levels from the volunteers and from seven foods across
three controlled diets), Penicillium citrinum (not detected in food but present in all four
volunteers’ saliva samples), and Xanthophyllomyces dendrorhous (extraction or PCR
contaminant detected at very low levels in all sample types, including controls).
Clavispora lusitaniae was the only OTU that was detected in multiple stool samples of
a volunteer but not in food or their saliva. However, its level narrowly surpassed the
defined limit of detection in stool (12 and 47 reads in one of three replicates of two
different V2 samples) and fell just short of the limit of detection in food (8 reads in
blueberries). C. lusitaniae is commonly found in the environment and was also detected
in dust from a shelf in the laboratory where the samples were processed (see Table S2F
at https://github.com/auchtung/Auchtung2018). Although it could have been coloniz-
ing V2, it was more likely detected by chance due to low-level contamination of food
that the volunteer ate or during sample processing. Unlike ITS2, 138 of the 162 total 16S
rRNA gene OTUs were detected in two or more stool samples from any volunteer, with
only 6/138 also present in saliva (see Fig. S3 and Table S2G and H at https://github
.com/auchtung/Auchtung2018). The 16S rRNA genes in food were not analyzed.
Due to the reduced stability of free RNA compared to DNA, ITS2 cDNA has the
potential to reveal more about the active community. The method has associated
caveats such as that rRNA is relatively stable, the amount of rRNA produced varies
across species, and even dormant cells can maintain high numbers of ribosomes. Yet
heating fungi for just 10 min at 70°C results in a 10-fold decrease in detectable RNA
(see Table S3 at https://github.com/auchtung/Auchtung2018), suggesting that the
contribution of fungi from cooked foods should be especially reduced. ITS2 cDNA
analysis of controlled-diet stool samples did not identify additional fungal species
(Fig. 2; see also Table S2I at https://github.com/auchtung/Auchtung2018); however,
relative to ITS2 DNA, there was an increase in the abundance of Candida and the
nonfungal microeukaryote Blastocystis, coupled with a decrease in the abundance of all
other abundant taxa (Fig. 3). The detection of Blastocystis was unanticipated, as the
FIG 3 Relative abundances of microeukaryotic taxa detected by ITS2 analysis of DNA or cDNA from stool.
Taxonomic differences between ITS2 DNA (blue) and cDNA (red) analyses following normalization to an
equal number of microeukaryotic reads/sample were determined. Twenty-five samples from four vol-
unteers on four controlled diets and one uncontrolled diet and from one volunteer on five uncontrolled
diets were analyzed. Boxes contain the interquartile range, with the center line denoting the median
relative abundance.
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most closely related Blastocystis sequences in GenBank have five mismatches (including
the two 3= nucleotides) with our reverse PCR primer, and suggests that Blastocystis RNA
was present in an especially high abundance relative to fungal RNA.
To determine whether any fungi were not detected due to primer bias, we also
amplified and sequenced the V6/V7 region of 18S rRNA genes from all stool samples
(see Fig. S4 and Table S2J at https://github.com/auchtung/Auchtung2018). There was
less diversity detected due to the greater sequence conservation of 18S rRNA genes
than of ITS regions, and there were no additional fungal lineages detected via 18S rRNA
genes that were not identified by ITS2 DNA analysis. However, three nonfungal
microeukaryotes were identified which dominated stool samples from V1 (98.7%
Dientamoeba) and V4 (91.1% Blastocystis and 8.9% Entamoeba).
To determine whether any fungi were undetected (despite being present in a
sample) due to uneven nucleic acid extraction by a Mo Bio PowerMag microbiome
(PMM) kit, DNA was also extracted from replicates of a subset of stool samples (all from
V1) by two additional methods: a Mo Bio PowerSoil kit used by the HMP (19) and a
protocol used by MetaHIT (20). Whereas ITS2 analysis of PowerSoil-extracted samples
and 18S rRNA gene analysis of MetaHIT-extracted samples found no additional OTUs,
ITS2 analysis of MetaHIT-extracted samples and 18S rRNA gene analysis of PowerSoil-
extracted samples yielded four and two additional OTUs, respectively, that were not
detected in the corresponding PMM-extracted samples (see Fig. S5 and S6 and Ta-
ble S2K to P at https://github.com/auchtung/Auchtung2018). However, the additional
OTUs were not abundant in V1 samples and were detected in PMM-extracted non-V1
samples, suggesting that their lack of detection here was due to chance rather than to
a bias in the protocol.
As an additional test to examine whether any fungi were not detected by molecular
analyses, and to gauge which fungi were able to survive gastrointestinal transit, stool
samples were also plated on fungus-selective Sabouraud agar. Many of the most
abundant fungal taxa identified by ITS2 sequencing of V1, V2, and V4 samples were also
isolated by culturing (see Table S2Q at https://github.com/auchtung/Auchtung2018).
Little was isolated from V3, in agreement with molecular analyses. C. albicans and
Saccharomyces were the only fungi identified from plates grown anaerobically, and no
fungal growth was detected on anoxic YCFA media (77), which can support the growth
of most gut bacteria (21). In summary, there is no evidence that any fungi in stool were
missed by biases in our approach to their detection; no fungi were consistently present
in the gut unless they also existed in the saliva or diet.
Examining fungal dynamics in gut-simulating bioreactors. The GI tract may not
be an accommodating environment for most fungi, as they must compete for nutrients
while resisting inhibitory compounds produced by commensal bacteria such as short-
chain fatty acids (22) and secondary bile acids (23). Fungal growth under the conditions
found in the GI tract can be tested in vitro through the use of bioreactors, which are
known to support growth of complex fecal bacterial communities (24). We examined
the identity and abundance of fungi present within the complex communities of
minibioreactor arrays after inoculation with stool from a healthy adult. Communities
were cultivated at 37°C in media that varied in composition, under conditions of either
an anoxic or hypoxic atmosphere (see Table S4 at https://github.com/auchtung/
Auchtung2018). Samples were collected between days 2 and 7, when the communities
typically had stabilized. Only one bioreactor, with high-sugar hypoxic media and a very
low diversity of bacteria, contained elevated levels of fungi (104 ITS2 copies/ng total
DNA on days 4, 5, and 6). C. albicans was the only fungal species detected in these
samples. Under conditions that resembled the healthy distal gut—low oxygen, simple
sugars, and a diverse bacterial community—there was no evidence of fungal persis-
tence.
Assessing Saccharomyces stability in the gut in the absence of dietary input.
We examined whether Saccharomyces, a genus of yeast that can survive gastrointestinal
transit and one of the most commonly detected fungi in most examinations of human
stool, would continue to be detected in a healthy adult volunteer after consumption of
Auchtung et al.
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a S. cerevisiae-free diet (see Table S5A at https://github.com/auchtung/Auchtung2018).
Although it has been shown that the probiotic S. cerevisiae var. boulardii is cleared
within a few days of consumption (25), the retention of other strains of Saccharomyces
has not been examined. Here, a volunteer collected all stool samples over the course
of a 15-day experiment as follows: 1 week on a regular diet, followed by 1 week on a
S. cerevisiae-free diet, followed by a final day where some foods containing S. cerevisiae
were consumed. Samples were examined both by ITS2 and 18S rRNA gene analysis.
Since there is only a single base pair in ITS2 distinguishing S. cerevisiae from related
species (and since there are none in 18S rRNA genes), the OTU may contain multiple
species of the genus and is referred to here as Saccharomyces. High levels of Saccha-
romyces were detected over the course of a normal diet (days 1 to 7), with the
final sample containing 86% Saccharomyces ITS2 reads (Fig. 4; see also Table S5B
at https://github.com/auchtung/Auchtung2018). After 2 days of consumption of a
S. cerevisiae-free diet by the volunteer, Saccharomyces comprised just 0.1% of the reads
(day 9). After unintentional consumption of a small amount of bread, there was a spike
in the relative abundance of Saccharomyces on day 10 to 16% of the reads. However,
by day 11 the abundance had again fallen to just 0.16% Saccharomyces. Reads of
Saccharomyces were below the level of detection in the remaining S. cerevisiae-free diet
samples (days 13 and 14). After the S. cerevisiae dietary exclusion had ended, Saccha-
romyces again became one of the most abundant taxa detected (day 15). The 18S rRNA
gene data were similar to the ITS2 data, with the relative abundances of Saccharomyces
just above the level of detection on days 9 and 11 and below the level of detection
on days 13 and 14 (see Fig. S7 and Table S5C at https://github.com/auchtung/
Auchtung2018). These data suggest that the Saccharomyces in the volunteer’s stool
may have entirely originated from dietary S. cerevisiae.
Tracing fluctuations in fecal Candida albicans to the oral cavity. Candida albicans
has long been studied for its role as an opportunistic pathogen (26). It is a leading
cause of nosocomial infection, particularly in immunosuppressed patients (27). In
our controlled-diet-experiment ITS2 analyses, it was the most abundant taxon
overall in both stool and saliva. C. albicans is frequently described as colonizing the
human GI tract; however, to our knowledge, there has been no study that has
demonstrated that this is true in healthy human individuals.
Since C. albicans is common in the oral cavity (15) and contributes to the formation
of dental plaque and the development of caries (28), we wanted to assess the
contribution of C. albicans in swallowed saliva to what is detected in stool. For all
experiments, saliva or blended stool was plated on Sabouraud plates containing
antibiotics. Possible C. albicans colonies were later spotted on chromogenic media to
distinguish from closely related species. First, we confirmed that there was a difference
in the levels of C. albicans in the saliva of a volunteer when the volunteer’s teeth were
FIG 4 Relative ITS2 abundance of Saccharomyces in stool over time as a Saccharomyces cerevisiae-free
diet was consumed. A logarithmically scaled chart showing the unrarefied relative abundances of
Saccharomyces reads among ITS2 sequences amplified from stool DNA of a human volunteer is shown.
Plant sequences were removed before analysis. The volunteer consumed a regular diet for 7 days and a
Saccharomyces cerevisiae-free diet for 7 days and then resumed a regular diet. Day 8 data represent
averages of results from two stool samples, and there was no sample on day 12.
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brushed with conventional fluoride toothpaste either once per day (at night) or after
every meal (3 to 4 times/day). Toothpaste helps remove plaque but does not signifi-
cantly impact the viability of C. albicans (29). The levels of C. albicans measured in the
oral cavity were relatively variable but were higher on average in saliva and plaque
when teeth were brushed just once per day (Fig. 5A). Next, we monitored the change
in abundance of C. albicans in stool when teeth were cleaned after every meal instead
of once per day and saw that levels decreased from 106 cells to 104 to 105 cells (Fig. 5B).
Finally, to confirm that the decrease was not due to unrelated artifacts, we monitored
C. albicans in stool while the protocols for cleaning of teeth were alternated: 2 days
cleaning after every meal, followed by 2 days cleaning once per day, each done four
times in total over 16 days. The total number of C. albicans colonies found in stool was
significantly greater (two-sample equal variance t test P  0.0007) after the volunteer
brushed just once per day (mean  8.3  105) than after the volunteer brushed after
every meal (mean  2.5  105) (Fig. 5C). A second volunteer who repeated a shorter
version of the experiment on nonconsecutive days also had less C. albicans in stool after
the volunteer brushed their teeth after every meal (Fig. 5D). Together, these experi-
ments suggest that a large portion of C. albicans in the stool of the volunteers was
derived from the oral cavity.
FIG 5 Candida albicans levels were decreased in the mouth and stool of healthy human volunteer(s) when teeth were
brushed more often. (A) Concentrations of C. albicans in saliva throughout days when an adult volunteer either did or did
not perform tooth brushing after eating. The volunteer consumed the same diet on both tooth-brushing protocols, the
experiment was performed for two different diets, and levels of C. albicans were measured in a sample of plaque at the
end of each day. (B) The total number of C. albicans cells in the stool of a volunteer over time (plotted on a log axis).
Following a period of brushing teeth just once per day, the volunteer performed tooth brushing after every meal for 8
consecutive days. The diet was not the same from day to day but contained similar levels of sugars throughout the time
period. (C and D) Lastly, the total number of C. albicans cells was measured in the stool of (C) a volunteer who alternately
followed different tooth-brushing protocols for 2 days over the course of 16 days or of (D) a second volunteer who twice
conducted each tooth-brushing protocol on nonconsecutive days. For all experiments, saliva, plaque, or stool was plated
on Sabouraud plates containing antibiotics. Possible C. albicans colonies were later spotted on chromogenic media to
distinguish the C. albicans colonies from closely related species and to adjust C. albicans numbers.
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DISCUSSION
Here we investigated fungal colonization of the healthy adult GI tract from multiple
perspectives. We conducted a controlled-diet experiment to examine the abundance
and identity of fungi present across multiple diets and then further investigated the
dynamics of the two most abundant fungi, Saccharomyces and C. albicans, when dietary
or oral hygiene practices were altered. We also examined fungi in bioreactors and in a
large data set of healthy adults. From all avenues of investigation, the evidence
suggests that fungi may not readily colonize the GI tracts of healthy adults in Western
society.
Although some bacteria have been demonstrated to be consistently present at low
levels in the GI tract (30), there was no evidence that that was the situation for any fungi
not derived from food or the oral cavity. Quantitative PCR analysis of controlled-diet-
experiment stool samples demonstrated that ITS2 were on average 3,000 less abun-
dant than 16S rRNA genes. Considering that many of the ITS2 amplicons were from
plants and that fungi often have higher ribosomal operon copy numbers than bacteria
(31, 32), the fungi in our samples were at extremely low abundance (~0.001% to 0.01%
of the population). This level of fungi is consistent with HMP metagenomic data (1);
although early studies found fungal levels in adult stool that were ~10 higher (8, 9),
the levels may have been overestimated due to extensive bacterial contamination of
fungal sequence databases.
Despite the volunteers having consumed the same controlled diets, the fungi
represented in volunteers’ stool DNA largely did not match by diet, due to the low
fungal content of the control foods, the variable composition of the volunteers’ oral
fungi, and the contribution of residual fungi from the volunteers’ regular diets. Only
four taxa were present in at least one sample replicate of every diet of a volunteer
(Candida albicans [V1, V2, and V3], Saccharomyces [V2], Aspergillus niger [V4], and
Penicillium sp. [V1]). Both A. niger and Penicillium sp. were linked to the regular diets of
individual volunteers and either were not detectable in the cDNA (A. niger) or were not
detectable in multiple other samples from the same volunteer in the S. cerevisiae-
free diet experiment (Penicillium sp.). This suggests there is little or no A. niger and
Penicillium colonization of the GI tracts of the volunteers. Saccharomyces and C. albicans
could have been from food and the mouth, respectively; however, to be certain of the
source, we examined these fungi further. When a healthy adult volunteer abstained
from consumption of food containing S. cerevisiae, the Saccharomyces OTU dropped
below the limit of detection within a few days, suggesting that there had been little or
no colonization. Malassezia, another fungal genus commonly detected in some studies
(1, 13) and the only fungal genus other than Saccharomyces to be detected in all three
longitudinal samples of multiple HMP volunteers, was not consistently detected in any
volunteer’s controlled-diet stool samples by any of our molecular approaches, despite
being present in the saliva of all volunteers. Malassezia may contaminate oral and stool
samples due to high abundance on skin and may not be as well adapted for surviving
passage through the GI tract.
C. albicans and related species have frequently been stated to colonize the GI tract
(33, 34), though all evidence seems to be from their presence in human stool samples
and from studies of inbred, typically antibiotic-treated animals. However, since the
average person is thought to swallow over a liter of saliva/day (35), the GI tract is
constantly dosed with oral microorganisms, including, for most people, species of
Candida (15). Here, we showed that when a healthy adult volunteer increased the
frequency of cleaning of teeth, the abundance of C. albicans in stool was lowered
10-fold to 100-fold. This suggests that the oral cavity may be the primary source of
C. albicans detected in the stool of healthy people. Indeed, the fungal component of
dental plaque of at least one cohort has been shown to be dominated by C. albicans
(36). Taking additional measures to further reduce oral C. albicans levels, such as extra
flossing and attention to elimination of plaque and reduction of consumption of refined
sugars, may reduce levels of C. albicans in stool even further. This may explain why
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Hoffmann et al. (37) observed a positive correlation between fecal Candida levels and
the consumption of carbohydrates. C. albicans is also much more common in Western
populations, where refined sugar consumption is high (38, 39). Healthy mice are usually
resistant to colonization by C. albicans (40); however, they are not typically maintained
on a diet containing the simple sugars that encourage the growth of C. albicans. For
one study where mice were fed a nutritionally adequate diet that included 10%
sucrose, the mice had a sustained level of C. albicans in their feces (41). However,
the oral cavities of the mice were not examined, so the role of that site in
contributing to the C. albicans population is uncertain. Some work has been done
investigating the effects of certain dietary compounds on C. albicans (42, 43), but
more studies on the oral ecology of this opportunistic pathogen are needed. In
bioreactors designed to mimic in vivo conditions in parts of the GI tract, we saw that
C. albicans grew only when oxygen and a relatively high concentration of simple
sugars were present. These conditions are relevant to the oral cavity and upper
gastrointestinal tract, but not to the colon, where most bacteria are found. The
bacterial community in the C. albicans growth-supporting bioreactors was also
relatively simple, unlike that of a healthy GI tract, and therefore might have
presented less resistance to fungal growth. It is possible that C. albicans colonizes
both the mouth and the upper GI tract; in this regard, however, C. albicans may be
akin to the oral bacteria that exacerbate disease when they colonize the gut (44,
45). Just as the Centers for Disease Control and Prevention recommends maintain-
ing good oral health for preventing mouth, throat, or esophagus candidiasis
(https://www.cdc.gov/fungal/diseases/candidiasis/thrush/), patients suffering from
or at risk for developing a gastrointestinal disease might also benefit from increasing
the attention that they pay to dental hygiene.
We conducted multiple analyses to ensure that fungi that might be colonizing the
gastrointestinal tracts of volunteers were not missed by ITS2 sequencing of DNA. ITS2
from cDNA, 18S rRNA genes from DNA, ITS2 and 18S rRNA genes from DNA extracted
by alternate methods, and fungi that grew on agar plates were also analyzed. No
additional fungal species were detected by ITS2 cDNA and 18S rRNA gene analysis,
though both approaches did reveal the presence of nonfungal microeukaryotes. ITS2
cDNA analysis specifically detected only high levels of C. albicans and the nonfungal
microeukaryote Blastocystis, a known colonizer of the GI tract (46). The two alternative
DNA extraction methods tested did not reveal any problems with detecting fungi
in DNA extracted by our standard protocol. Additionally, most fungi isolated in
culture grew only on plates of rich media in the presence of oxygen. There was no
fungal growth on an intestine-like medium which is able to support the growth of
nearly every bacterial species detected in stool by 16S rRNA gene analysis (21). In
summary, the additional analyses failed to find deficiencies in our approach to
fungal detection.
Analysis of the accumulation of 16S rRNA gene and ITS2 OTUs detected in healthy
adult HMP stool samples demonstrated that while bacterial populations are similar
from one individual to another and community sampling approaches saturation, fungal
populations are more variable, and the community continues a steady rate of revealing
new representatives as more samples are examined. In fact, in the entire cohort of 100
individuals, there were more ITS2 OTUs than 16S rRNA gene OTUs. This may, in part,
have been because unique food-derived bacteria are hard to detect among the
members of the enormous endemic bacterial population. An example is the genus
Lactobacillus; once perceived to be autochthonous members of the GI tract, most
species are actually derived from the mouth, from food, or from the upper GI tract (47).
Whereas Lactobacillus sequences represent a minor fraction of the 16S rRNA gene data
from stool, low-abundance fungal species from food and the oral cavity would be the
predominant ITS2 OTUs detected under conditions in which there had been little or no
fungal colonization of the GI tract.
We have presented multiple lines of evidence supporting the hypothesis that there
are few or no fungal species indigenous to or colonizing the GI tracts of healthy adults
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in Western society. There are many possible reasons why gut-colonizing fungi might
have been missed, but we consider them unlikely. They include the following possi-
bilities. (i) Gut-specific strains might have been masked by other closely related
fungi—at least for C. albicans, the same strain has been found in different parts of the
body (48). (ii) Disease-free gut fungus-colonized individuals might have been missed
due to our having examined only four volunteers. (iii) Fungi growing in the GI tract
might have been degraded to the extent that they became completely undetectable in
stool—even free DNA is known to survive transit (49). (iv) Fungi might colonize in
extremely low numbers and bloom in the GI tract under healthy conditions not
examined. (v) Fungi might exist in close association with host cells such that very few
fungi are shed with fecal material. However, there are many reasons why fungi might
not colonize, including inadequate physiological machinery for success in the environ-
ment, defenses of the mature human immune system, and a loss of gastrointestinal
microbial diversity through recent or long-term evolution or exposures.
Many of the fungi detected by molecular analyses are not optimized for growth at
37°C (50, 51) and lack the genes and physiological traits reflective of an adaptation to
the environment of the GI tract. Although some fungi such as C. albicans are able to
survive the healthy adult GI tract, in order to colonize it, they face intense bacterial
competition for nutrients and the threat of challenge by antimicrobials not present in
the oral cavity, such as reactive nitrogen intermediates (52), peptides (53), and second-
ary bile acids (23). Physiologically relevant concentrations of short-chain fatty acids can
also be fungistatic (22). Notably, the gut environment is not fully established in young
children, where the immune system and competing bacterial communities are still
developing. Though more data are needed, some studies have shown increased fungal
diversity in children (54, 55).
Fungi may not persist in the GI tracts of those with a healthy immune system, and
conversely, fungal colonization may be a symptom of illness. Those with a suppressed
immune system are particularly susceptible to fungal invasion (56); the immune re-
sponse mediated via multiple pattern recognition receptor families is important in the
defense against fungi (57, 58). Furthermore, there are a multitude of studies showing
fungal differences between healthy individuals and sick patients. However, there is a
difference between detection of a microbe and proving that it colonizes that location—
since the sick may spend more time indoors and/or eat differently, they could be
exposed to different fungi. Therefore, it is necessary to consider confounding lifestyle
and dietary differences to know whether any fungal gut colonizers are associated with
the disease. If fungal colonization of the gut is associated only with disease, however,
it might be beneficial to treat more patients with antifungals, especially if side effects
can be avoided. In addition, the detection of increased levels of gastrointestinal fungi
could alert clinicians to undiagnosed disorders.
Any indigenous or colonizing fungi might have disappeared as human diet and
society has evolved. With modernization have come activities that limit microbial
survival, transmission, and exposure, resulting in a loss of bacterial diversity and
helminths from the GI tracts of humans (59, 60). There have been few microbiome
studies conducted on non-Western communities, and most did not examine fungi. In
the stool sample data set generated by Yatsunenko et al. (8), we found that subjects
from Malawi and Venezuela had an increased proportion of fungal reads and an
increased incidence of having any fungi compared to subjects from the United States
(see Text S1 at https://github.com/auchtung/Auchtung2018). Yet, with the low overall
abundance of fungi in human guts, deeper sequencing is needed to confidently
determine whether there are increased levels of fungi in non-Western populations. In
addition, measurements of oral and dietary fungi are needed to assess whether
differences in stool fungi are due to increased levels of transient fungi or to genuine GI
tract colonization.
It is also possible that humans lost gut fungi when they diverged from chimpanzees,
primates, or more distant relatives, corresponding to changes in our diet and GI tract
morphology (61). It has been shown that humans have had a loss of bacterial and
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archaeal diversity relative to other apes (62, 63). However, there have been few studies
on fungi in the GI tracts of animals. Examination of stool from domesticated dogs and
a wild gorilla found high fungal diversity (64, 65). Fungal populations in the guts of
laboratory rodents show large variation from study to study, and many of the detected
species can be explained by the presence of fungi in their chow and bedding (2, 66–69)
(see Text S2 at https://github.com/auchtung/Auchtung2018). Clearly, much more re-
search on fungal communities in the GI tracts of wild animals is needed.
In summary, we have shown that fungi detected from the GI tracts of volunteers
across multiple diets were at very low abundance, were only transiently present from
the diet or oral cavity, and did not grow when placed in gut-like conditions. In addition,
the levels of two common fungal species in stool were shown to be directly affected by
altering the oral hygiene or the dietary consumption of the volunteers, and analyses of
data from larger cohorts were consistent with the possibility that fungi may not
colonize the guts of healthy adults in Western society. More studies are needed that are
mindful of dietary and oral fungi and that examine the relative contributions of
immunological defenses, fungal ecology, and human evolution to limiting fungal
persistence in the healthy modern adult GI tract.
MATERIALS AND METHODS
Comparison of fungi with bacteria/archaea in HMP stool samples. ITS2 and 16S rRNA gene
sequences from the Human Microbiome Project are available at NCBI (BioProject PRJNA356769) and the
Human Microbiome Project website (http://www.hmpdacc.org), respectively. There were 148 samples
that had at least 1,000 plant-filtered ITS2 and 16S rRNA gene reads. The data sets were rarefied to 1,000
reads by the use of single_rarefaction.py (70). Rarefaction curves were calculated with mothur v1.36.1,
which uses a resampling-without-replacement approach (71).
Controlled-diet experiment. Four healthy people (ages between 25 and 37), all born and primarily
raised on different continents (but who were residing in Houston, TX, for the duration of the study), with
diverse dietary habits, consumed four identical diets (see Table S2A and B at https://github.com/
auchtung/Auchtung2018). The diets were composed of a variety of food groups, largely low in fungi
(except diet D), and were kept simple to facilitate analysis of all components. Volunteers did not consume
probiotics or vitamins and did not chew gum but were allowed coffee, tea, and salt, as long as those
foods were submitted for fungal sequencing analysis. There was no limit to the amount of food
consumed. The diets were consumed nonconsecutively and in no set order over the course of 1 month,
April 2016. Volunteers had the option to consume a 100-mg Brilliant Blue Lake (FD&C Blue 1 dye) pill at
the start of each diet to clarify via staining that stool samples were primarily resulting from the particular
diet and were ready to be collected. Volunteers collected a stool sample (12 to 222 g; mean, 77 g)
following the appearance of the particular diet (or dye) in their stool. Saliva samples (typically three/diet)
were collected at time points that were at least 2 h apart and at least 1 h after eating to reduce the
number of plant particles that might obscure the detection of fungi. All samples were frozen at 80°C
until nucleic acid extraction.
Using a Mo Bio PowerMag microbiome kit (including the phenol step), nucleic acids were extracted
from dietary components, saliva (200 l), and total stool which had been blended in 2 vol of prereduced
phosphate-buffered saline (PBS)–0.5 g/liter cysteine (50 l). For V1, replicate stool samples were
extracted using the MetaHIT (20) and Mo Bio, Inc., PowerSoil protocols (19). All stool samples used for
PCR were sampled in triplicate. Nucleic acids were treated with either RNase A (Qiagen) or DNase I (New
England Biolabs). Representative RNA samples were analyzed by spectrophotometry and visualized on an
agarose gel to confirm purity and integrity. rRNA was reverse transcribed using a Maxima H Minus kit
(Thermo Fisher) with primer-specific conversion using ITS4R. As a control, RNA sample replicates with no
reverse transcriptase were processed concurrently; DNA was rarely amplified, and taxa abundant in test
samples were not detected (see Table S2F at https://github.com/auchtung/Auchtung2018). The ITS2
region, 18S rRNA gene V6/V7, and 16S rRNA gene V4 were amplified with primers ITS3F-ITS4R, 1152F-
1428R, and 515F-806R, respectively, and sequenced on an Illumina MiSeq platform; reads were merged,
clustered, subjected to chimera filtration, and mapped against databases as described previously (1).
Nucleic acid from each of the three stool samples was amplified for ITS2 DNA, ITS2 cDNA, and 18S rRNA
genes, but only a single randomly chosen replicate was amplified for 16S rRNA gene analysis. Every
sequenced region averaged 10,000 reads/sample. Because the maximum amount of sequencing
barcode bleed-over seen in 42 control samples was 7 reads, an OTU was considered present if there were
at least 10 reads detected in a sample. Three PBS/collection dish/blender controls yielded no isolates and
10 ITS2 DNA and cDNA reads (see Table S2F at https://github.com/auchtung/Auchtung2018). For
blending, nucleic acid extraction, and PCR amplification, the order of sample processing was randomized.
All primer sequences are listed in Table S8 at https://github.com/auchtung/Auchtung2018. Taxon box
plots and stacked bar plots were generated in R (72), utilizing the phyloseq package (73).
Replicates of all blended stool samples (50 l) were plated on Sabouraud agar (4% dextrose, 1%
peptone, 100 g/ml ampicillin, 50 g/ml chloramphenicol) and grown at both room temperature and
37°C under conditions of ambient and anoxic (90% N2, 5% CO2, 5% H2) atmospheres. Colonies were
identified by Sanger sequencing following PCR amplification with ITS3F-ITS4R and, where necessary, 18S
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rRNA gene-targeting 1152F-1428R or 16S rRNA gene-targeting 27F-907R (74). To look for fungi that grow
under conditions more physiologically similar to those of the gut, frozen replicates of the uncontrolled-
diet samples were later plated on YCFA media (77) containing 50 g/ml chloramphenicol, 100 g/ml
ampicillin, 10 g/ml tetracycline, and 50 g/ml kanamycin with or without 250 g/ml bovine bile and
placed in an anoxic atmosphere for at least 2 weeks.
ITS2-specific primers ITS3F and ITS4R and 16S rRNA gene-specific primers Bact1369F and Prok1492R
were used in quantitative PCR analysis of controlled-diet fecal DNA samples using Applied Biosystems
Power SYBR green PCR master mix following the manufacturer’s instructions, with 60 s (ITS2) or 30 s (16S
rRNA gene) of annealing/extension at 60°C. To create nonsupercoiled standard curve templates (75), DNA
from Malassezia cuniculi (450-bp ITS2) or Escherichia coli rrsA was amplified using the primers specified
above, except that the procedure also used an additional 64 (ITS3F and ITS4R), 18 (Bact1369F), or 19
(Prok1492R) 5= nucleotides (nt) so that quantitative PCR primers would not have to anneal to the very
end of the template.
Bioreactors. Experiments were conducted in minibioreactor arrays as previously described (24) using
five different media under conditions of either an anoxic (5% CO2, 95% N2) or hypoxic (2% O2, 5% CO2,
93% N2) atmosphere (see Table S4 at https://github.com/auchtung/Auchtung2018). For each medium/
atmosphere condition, triplicate 15-ml reactors were inoculated with a 25% fecal slurry (containing 75%
reduced PBS) and allowed to sit for 16 h (anoxic reactors) or 4 h (hypoxic reactors) before flow was
initiated at 1.825 ml/h (anoxic) or 3.75 ml/h (hypoxic). The hypoxic bioreactors had a shorter initial wait
and higher flow rate to more closely resemble the upper GI tract. Samples for DNA extraction (as
described in reference 76) and sequencing were collected daily from each reactor over the course of
7 days. Quantitative PCR was performed as described above.
Saccharomyces experiment. A single healthy adult volunteer ate regularly for 1 week and then
avoided eating foods containing S. cerevisiae for 1 week, followed by 1 day of eating foods with a large
amount of S. cerevisiae (see Table S5A at https://github.com/auchtung/Auchtung2018). Over the course
of the 15 days, the stool samples were collected and frozen, typically once daily. Two months later,
samples were collected during 3 days of a regular diet. DNA from approximately 250 mg frozen stool was
extracted using the Mo Bio PowerSoil protocol and analyzed as described above, with an average of
55,000 ITS2 and 25,000 18S rRNA gene reads/sample. We defined the limit of detection as 10 reads
of Saccharomyces, since 27 pure culture controls had 10 reads from barcode bleed-over.
Candida albicans experiments. To test the effect of increased tooth brushing (after every meal,
within 30 min) on C. albicans levels in saliva of a healthy adult volunteer, for every hour from 7 a.m. to
9 p.m. over 2 consecutive days during which the same diet was consumed, 200 l of saliva was spread
on Sabouraud media containing ampicillin and chloramphenicol. The numbers of colonies were counted
after 24 h at 37°C and were adjusted after 48 h following verification of the presence of previously small
colonies. Up to 10 colonies/plate were spotted onto chromogenic BBL CHROMagar Candida (BD) and
grown for at least 48 h to distinguish C. albicans from related species. Since the cells do not grow as well
on the chromogenic agar, resulting in fewer colonies, the medium was used only to assess the identity
of Sabouraud-grown colonies. The reported number of C. albicans cells in each sample was corrected
using these data.
To test how the levels of C. albicans in stool of healthy volunteers were affected by variations in
tooth-brushing protocols, the following experiments were conducted. First, over the course of 8 days,
during which time the volunteer brushed their teeth after every meal instead of once per day, entire stool
samples were collected and blended with PBS, and 150 l was plated in triplicate on Sabouraud media
containing antibiotics. In a second experiment, the following protocol was repeated by the same
volunteer four times: brushing of teeth once per day (at night) for 2 days and then after each meal for
2 days. For the course of the experiment, the volunteer defecated once per day at the same time
(30 min). On the day after each 2-day protocol, a full stool sample was collected and blended with PBS,
and 50 l was plated in triplicate. A variation of this experiment was conducted by a second volunteer
but on nonconsecutive days and following each protocol twice. Volunteers were instructed to eat similar
amounts of sugary foods between the protocols, avoid Penicillium-rich cheeses, and avoid heavy
consumption of alcohol. At the end of the stool experiments, all presumed C. albicans colonies from at
least one random replicate plate/day were spotted onto chromogenic agar as described above. The t test
was performed in Excel.
Ethics statement. The Institutional Review Board of Baylor College of Medicine approved all study
protocols. All participants provided written informed consent (protocols H-32521 and H-29645).
Data availability. Sequence data were deposited in NCBI’s Sequence Read Archive (BioProject
PRJNA379437) and GenBank (accession no. KY931930 to KY932673 and KY932725 to KY933059).
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